
CAS 1509916-03-3
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
3 Produkte.
Cergutuzumab
CAS:<p>Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine directed against carcinoembryonic antigen (CEA) containing an IL2v-moiety with abolished IL-2 receptor (IL-2R) α binding.</p>Cergutuzumab Amunaleukin
CAS:<p>Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine directed against carcinoembryonic antigen (CEA) containing an IL2v-moiety with abolished IL-2 receptor (IL-2R) α binding.</p>Cergutuzumab amunaleukin
CAS:<p>Cergutuzumab amunaleukin (CEA-IL2v) is a CEA-targeted IL-2 variant immunocytokine for combination cancer immunotherapy with anti-tumor activity.</p>Reinheit:98% (SDS-PAGE); 99.7% (SEC-HPLC) - 98% (SDS-PAGE); 99.7% (SEC-HPLC)Farbe und Form:LiquidMolekulargewicht:162.05 kDa


